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Abstract
Parthenogenetic embryonic stem cells are considered as a promising resource for regeneration medicine and powerful tools
for developmental biology. A lot of studies have revealed that embryonic stem cells have distinct microRNA expression
pattern and these microRNAs play important roles in self-renewal and pluripotency of embryonic stem cells. However, few
studies concern about microRNA expression pattern in parthenogenetic embryonic stem cells, especially in non-human
primate—the ideal model species for human, largely due to the limited rhesus monkey parthenogenetic embryonic stem
cells (rpESCs) available and lack of systematic analysis of the basics of rpESCs. Here, we derived two novel rpESCs lines and
characterized their microRNA signature by Solexa deep sequencing. These two novel rpESCs shared many properties with
other primate ESCs, including expression of pluripotent markers, capacity to generate derivatives representative of all three
germ layers in vivo and in vitro, maintaining of euploid karyotype even after long culture. Additionally, lack of some
paternally expressed imprinted genes and identity of Single-nucleotide Polymorphism (SNP) compare to their oocyte
donors support their parthenogenesis origin. By characterizing their microRNA signature, we identified 91 novel microRNAs,
except those are also detected in other primate ESCs. Moreover, these two novel rpESCs display a unique microRNA
signature, comparing to their biparental counterpart ESCs. Then we analyzed X chromosome status in these two novel
rpESCs; results suggested that one of them possesses two active X chromosomes, the other possesses only one active X
chromosome liking biparental female embryonic stem cells. Taken together, our novel rpESCs provide a new alternative to
existing rhesus monkey embryonic stem cells, microRNA information expands rhesus monkey microRNA data and may help
understanding microRNA roles in pluripotency and parthenogenesis.
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Introduction
Parthenogenetic activated blastocysts are promising resource for
derivation of embryonic stem cells (ESCs), owing to comparable
isolation efficiency with biparental counterparts and histocompat-
ibility with oocyte donors [1–3]. Because of lacking paternal
genome, parthenogenetic ESCs have unique imprinting pattern
and have aroused a lot of interest. Rhesus monkey (Macaca mulatta),
one of the most well-studied non-human primate, is an ideal model
for ESCs-based cell replacement therapy due to its genetic and
physiological similarity with human [4,5]. However, there are only
limited studies [6,7] concerned about the rhesus monkey
parthenogenetic embryonic stem cells (rpESCs), largely due to
the limited rpESCs lines available and lack of systematic analysis of
the basics of rpESCs.
MicroRNA (miRNA) belong to a group of single-stranded
noncoding RNAs that are 21–23 nucleotides (nt) in length [8].
They bind to the complementary sites within the 39UTRs of
cognate mRNAs, leading to the degradation, deadenylation, or
translational repression of the target mRNAs, which provide a
crucial and pervasive post-transcriptional gene regulation [9].
Increasing evidence suggests that miRNAs play important role in
self-renewal, differentiation and reprogramming of ESCs or iPS
[10,11]. Investigations of the miRNA expression patterns in
human ESCs have revealed a unique miRNA signature distinct
from differentiated cells [12–18]. Our previous research suggested
that rhesus monkey ESCs from in vitro fertilization (IVF)
blastocysts also share a unique miRNAs set, miR-302 cluster,
which were reported to be highly enriched in human ESCs, were
the most rhesus monkey ESCs enriched miRNAs [19]. The
parthenogenetic ESCs would exhibit many themselves own
characteristics, due to the absence of paternal genome, although
they share many properties with their biparental counterparts.
However, the miRNA expression profiling in parthenogenetic
ESCs is largely unknown.
In current study, we isolated two novel rpESCs, and
characterized their miRNA signature by a novel, robust and
reproducible Solexa deep sequencing approach. On basis of
sequencing data, we compared rpESCs with IVF rhesus monkey
ESCs, and analyzed their X chromosome status.
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Isolation and characterization of two novel rhesus
monkey parthenogenetic ESCs
A total of 7 parthenogenetic activated blastocysts with
prominent inner cell mass(ICM) were selected for immunosurgery,
and 3(42%) ICMs were successfully isolated and plated on feeder
cells. All the ICMs attached to the feeder cells within 48 hours,
and 2(28%) ESC-like ICM-outgrowths appeared after 7,8 days.
These ICM-outgrowths were manually dissociated into 4,6
smaller clumps with a microscalpel, excised from the feeder cells
and replated onto fresh feeder cells. Clones with distinct boundary
and a high nuclear to cytoplasmic ratio were selected for further
propagation. Finally, two rhesus monkey parthenogenetic ESC
lines were obtained (28%), designated as Pa2.2 and Pa3. These
two novel rpESCs shared common morphological property with
other primate ESCs: flat clones, remarkable boundary with feeder
cells, high ratio of nuclear to cytoplasmic and prominent nucleoli
(Fig. 1A). These two novel rpESCs showed strong alkaline
phosphatase activity (Fig. 1A), and expressed high level pluripotent
markers, including Oct-4, Nanog, SSEA-4, TRA-1-60, TRA-1-81
(Fig. 1A), Sox-2 and Rex-1 (Fig S1).
These two rpESCs could spontaneously differentiate into cell
lineages representative of all three embryonic germ layers by
embryoid body (EB) formation method, including neuron-like
cells, contractive cardiomyocytes and endoderm-like cells (Fig. 1B).
When the rpESCs clones were injected into the hind leg muscle
of SCID mice, after 6,7 weeks, teratomas could be detected, and
the histological characterization revealed that ectoderm-(neural
tube and Squamous epithelium), mesoderm-(cartilage, adipose),
Figure 1. Isolation and characterization of two novel rhesus monkey parthenogenetic ESCs. A, morphology and pluripotent markers.
From left to right are Phase-contrast micrograph of an ESC colony growing on mEFs, Alkaline phosphatase staining, OCT-4, NANOG, SSEA-4, TRA-1-60
and TRA-1-81. Up is Pa2.2, down is Pa3; B, differentiation in vitro. From left to right are neuronal marker Tuj III, Cardiomyocytes marker a-cardiac
actinin and Endoderm marker a-fetoprotein. Up is Pa2.2, down is Pa3; C, teratomas. Up is Pa2.2, from left to right are Squamous epithelium, adipose
and respiratory epithelia (inset shows respiratory cilia). Down is Pa3, from left to right are neural tube, cartilage and intestinal epithelia; D, G-banding
karyotypes. Up is Pa2.2, down is Pa3; Size bar (A, 100 mm; B and C, 50 mm).
doi:10.1371/journal.pone.0025052.g001
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were present in teratomas from these two novel rpESCs (Fig. 1C).
Pa2.2 have been cultured for more than 120 passages, and Pa3
for more than 80 passages. Detailed G-banding analysis revealed
that all of the two rESC lines were karyotypically normal, with a
diploid set of 42 chromosomes (40+XX) (Fig. 1D), even after long
time cultivation in vitro and repeat freezing.
Identification of parthenogenetic origin
In normal fertilized embryonic stem cells, imprinted genes
express predominantly from maternal or paternal alleles respec-
tively. Paternally expressed imprinted genes would not be
detectable in rpESCs, since both alleles are of maternal origin.
We used RT-PCR to analysis two maternally and eight paternally
expressed imprinted genes in our novel rpESCs and a IVF-origin
rhesus monkey ESCs control (IVF3.2) [19]. Expectably, H19 and
UBE3A, two imprinted genes normally expressed predominantly
from the maternal allele were detected in both rpESCs and IVF-
origin control (Fig. 2A). However, paternally expressed imprinted
genes, PEG3 and SGCE were also detected in rpESCs (Fig. 2B). In
addition, paternally expressed imprinted genes including PEG10,
ZIM2 and MEST were expressed in Pa3, but not in Pa2.2
(Fig. 2B). Only three paternally expressed imprinted genes we
tested, SNPRN, NDN and MAGEL2, were absent from all two
rpESCs (Fig. 2B). All of these eight paternally expressed imprinted
genes could be detected in IVF–origin control (Fig. 2B).
Since the diploid genome in parthenogenetic ESCs were
origined from identical sister chromatids in MII oocyte by
retention of the second polar body, on the hand, single-nucleotide
polymorphism (SNP) would be identical between oocyte donors
and their daughter cells, on the other hand, each homologous
chromosome pair in parthenogenetic ESCs might be expected to
display high levels of homozygosity. Indeed, twelve SNP loci we
analyzed were uniform between Pa2.2 and its oocyte donor
97360# monkey, Pa3 and its oocyte donor 97352# monkey
respectively (Fig. 2C). However, two of twelve SNP loci we
analyzed, TNF-82 and CCR9-325, displayed heterozygosity in
Pa2.2 rpESCs, but Pa3 rpESCs displayed homozygosity in all of
these twelve SNP loci (Fig. 2C).
Although some paternally expressed imprinted genes indeed
were detectable in two rpESCs, lack of other paternally expressed
imprinted genes and identity of SNP between rESCs and oocyte
donors could be as evidence for parthenogenetic origin.
Small RNA Sequencing and miRNA expression profiles in
the rpESCs
Sequencing of small RNA libraries yielded 12861523 and
12922804 raw reads from Pa2.2 and Pa3 respectively. After
filtering, we obtained 11199549 (Pa2.2) and 11699247 (Pa3) clean
reads (18–30 nt). The length distribution of these clean reads
centers at 22–23 nt, coinciding with the scope of miRNA length.
Aligned with the rhesus monkey genome (rheMac2) by SOAP
(Short Oligonucleotide Alignment Program) [20], a total of
8593355 (Pa2.2) and 8443160 (Pa3) sequences were mapped to
the genome (Fig. 3A). It showed that miRNA was the major
component in the small RNA library of rpESCs (Fig. 3B), about
60% of which were matched to reference miRNAs in each sample,
and the proportion of other annotated RNAs was less than 15%.
Notably, about 25% of the sequences could not be annotated
because of the low coverage (66) and relatively poor annotations
of the released rhesus macaque genome. These unknown
sequences were subjected to further analysis for identifying novel
miRNAs.
After matched to 466 reference miRNAs of rhesus macaque,
345and 346 known miRNAs were detected inPa2.2 and Pa3,
respectively, with absolute counts ranging from 1 to 1566502
(Table S2). The normalized expression of miRNA was reflected by
the expression of transcript per million (TPM). Comparison of the
known miRNA between Pa2.2 and Pa3 showed that the holistic
expression profiles in these two novel parthenogenetic rESCs were
Figure 2. Expression of maternally and paternally expressed imprinted genes. A, expression of maternally expressed imprinted genes in
IVF3.2 (female IVF rhesus monkey ESCs) and rpESCs. B, Expression of paternally expressed imprinted genes in IVF3.2 (female IVF rhesus monkey ESCs)
and rpESCs. C, SNP analysis of oocyte donors and rpESCs.
doi:10.1371/journal.pone.0025052.g002
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(Fig. 3C).
We also analyzed miRNA cluster expression patterns and the
results revealed that miRNAs from miR-302 cluster, miR-182/
miR-183/miR-96 cluster and miR-143/miR-145 cluster were the
most rpESCs enriched miRNAs. Fig. 3D gave the top 10 enriched
miRNAs clusters in rpESCs. Interestingly, miR-371–373 cluster,
which was reported to be a highly enriched miRNA cluster in
human ESCs [12,14,17,18], only represented a moderate
expression level in our in rpESCs (table S3). In addition, miRNAs
from C19MC, another human ESCs-enriched miRNAs cluster,
was lower than minimum threshold expression level in rpESCs
(table S3).
Identification of novel miRNAs
We predicted novel miRNA genes among the unannotated
sequences by Mireap (http://sourceforge.net/projects/mireap/).
Briefly, according to the characteristic hairpin structure of miRNA
precursor, the unannotated small RNA tags, which could be
mapped to genome, were downloaded with their flanking
sequences and analyzed for secondary structure, Dicer cleavage
site and minimum free energy (mfe). Eventually, there were 91
novel miRNAs shared by these two novel rpESCs (table S4), and
23 of them had the homologs to reference miRNAs (miRBase
V16.0) in other species.
Comparison of miRNA expression between
parthenogenetic and IVF rhesus monkey ESCs
Although parthenogenetic ESCs shared many properties with
their IVF counterpart, the question are there some difference in
miRNA level between them is still unknown. Here, we compared
miRNA expression profiles of 230 miRNAs(counts TPM.3) in
rpESCs with IVF-origin rhesus monkey ESCs, IVF3.2 and
IVF3.3, which we recently reported [19]. With respect to
comprehensive miRNAs expression pattern, both of two type
rhesus monkey ESCs represented high similarity (Fig. 4A).
Especially, all of miR-302b, miR-182, miR-183, miR-93 and
miR-99b, which were from rpESCs enriched miRNAs cluster
(Fig. 3D), were also highly expressed in IVF3.2 and IVF3.3 (counts
TPM.10000). Additionally, miR-103, miR-21 and miR-378
possessed very high expression level (counts TPM.10000) in
despite of origin from parthenogenesis or IVF. Whereas,
hierarchical clustering analysis distinctly separated rpESCs from
IVF-origin rhesus monkey ESCs (Fig. 4A), indicating that rpESCs
had a distinguishable signature of miRNA expression. There-
fore, we listed remarkable up- or down-regulated(fold-chan-
ge.2,p,0.05) miRNAs comparing with IVF-origin rhesus
monkey ESCs (Fig. 4B).
X-chromosome status in rpESCs
Since both X-chromosome in parthenogenetic ESCs were
origined from single X-chromosome in MII oocyte, epigenetic
status of X-chromosome, especially for X-chromosome inactiva-
tion (XCI), were very important for parthenogenetic ESCs.
Therefore, we analysed X-chromosome status in our two novel
rpESCs based on miRNA expression data.
For total expression pattern of chromosome-linked miRNAs, we
observed that X-linked miRNAs were obviously overexpressed in
Pa3 (p,0.05) comparing with Pa2.2 and other two IVF-
origin rhesus monkey ESCs (one female IVF3.2, one male
IVF3.3)(Fig. 5A Left). However, Pa2.2 and two IVF-origin rhesus
monkey ESCs had no statistical difference (Fig. 5A left).
Simultaneously, the expression level of 1-chromosome-linked
miRNAs was similar in all rhesus monkey ESCs (p.0.05)
(Fig. 5A right). Furthermore, we visualized expression profiles of
chromosome-linked miRNAs using CGH-Explorer. Similar to the
total expression pattern, in moving average plot of the X
chromosome, X-linked miRNAs in Pa3 were prominently
upregulated compared with Pa2.2, IVF3.2 and IVF3.3, although
all of rhesus monkey ESCs had an accordant trend (Fig. 5B left).
Whereas, the other rpESC, Pa2.2 was consist with IVF3.2 and
IVF3.3 (Fig. 5B left). For expression profiles of 1-chromosome-
linked miRNAs, no matter of origin from parthenogenesis or IVF,
all of rhesus monkey ESCs showed a very parallel moving average
plot (Fig. 5B right). These results suggested that both of X
chromosomes were activated in Pa3, while one of them was
inactivated in Pa2.2.
In order to further validate the results detailed above, we
measured XIST, which was expressed in XCI, using semi-
quantitive PCR. Expectably, the transcript of XIST had a high
expression level in IVF3.2 and Pa2.2. On the other hand, the RT-
PCR products of XIST could not be detected in IVF3.3 and Pa3
(Fig. 5C). These results supported the coclusion above that Pa3
had two activated X chromosomes, but Pa2.2 had only one.
Discussion
Here, we isolated two novel rpESCs on 28% efficiency,
comparable to biparental counterpart. These rpESCs shared
many properties with other primate ESCs, including expression of
pluripotent markers, capacity to generate derivatives representa-
tive of all three germ layers in vivo and in vitro, maintaining of
euploid karyotype even after long culture. Because of lack of
paternal genome, paternally expressed imprinted genes were
expected to be absence in rpESCs. However, in our two novel
rpESCs, paternally expressed imprinted genes including PEG3,
SGCE, PEG10, ZIM2 and MEST could be detectable at least in
one rpESCs, consist with other available parthenogenetic rhesus
monkey ESCs [7]. Nevertheless, SNPRN, NDN and MAGEL2
were absent from both our rpESCs and others [7]. Although
twelve SNP loci we analyzed were uniform between rpESCs and
their oocyte donors, Pa2.2 represented heterozygousity to some
extent. This phenomenon recently observed also in mouse and
human parthenogenetic ESCs [1,21,22], due to homologous
crossing-over and recombination during meiosis I.
In our two rpESCs, mir-302 cluster had a very high expression
level, consisting with previous studies that mir-302 cluster was
high-riched in human ESCs [12–18]. Intriguingly, mir-302 cluster
can reprogram cancer or somatic cells into iPS [23–25] revealed
that mir-302 cluster had important roles in maintaining pluripo-
tency of pluripotent cells. Recently, the roles of mir-302 cluster in
regulation of ESCs pluripotency have been clarified on some
extent. Nanog, Oct3/4, Sox2 and Rex1 are upstream regulators of
the miR-302 cluster promoter [26], miR-302a regulate ESCs cell
cycle by repressing cyclin D1 [27], and miR-302 impair early
differentiation by repress NR2F2 [28] and Lefty [29] at the post-
Figure 3. MiRNA expression profiles in the rpESCs. A, the counts and proportion of the mapped tags in the total clean reads; B, annotation of
13 RNA categories in the pie chart for Pa2.2 and Pa3 respectively. C, Scatter Plot of the expression of kwon miRNA in two novel rpESCs. D, rpESCs
enriched miRNAs clusters, the expression of miRNA were normalized as transcript per million(TPM). MiRNAs were considered to belong to the same
genomic cluster if the genomic locations of the first nucleotides of the predicted pre-miRNA hairpins were within 10 kilobases (kb).
doi:10.1371/journal.pone.0025052.g003
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reprogramming by accelerating mesenchymal-to-epithelial trans-
lation (MET) [30] and suppressing some epigenetic regulators
[23]. MiR-106a-363 cluster and miR-106b-25 cluster, which were
also high-riched in rpESCs, were reported to enhance reprogram-
ming by accelerating MET [30,31]. Interestingly, miR-371–373
cluster and C19MC miRNAs, which were reported to be highly
enriched in human ESCs [14,18], only represented a moderate or
almost undetectable expression level in our rpESCs respectively.
Additionally, some members of let-7 family were upregulated in
rpESCs. These results were also observed in some human ESCs
lines [13,16]. This variance in some miRNAs may reflect
difference in culture condition, developmental stage when ICM
were isolated.
Although rpESCs shared many properties with their IVF
counterpart, comparing between them on miRNA level would
help understanding universality and particularity of rpESCs. For
miRNAs which had a very high expression level(.10000 reads
TPM) in both parthenogenetic and IVF rhesus monkey ESCs,
members of mir-302 cluster, miR-106b-25 cluster have important
roles in maintaining of pluripotency. Interestingly, Guo and
colleagues recently reported [32] that members of miR-99b-125a
cluster increased the number of hematopoietic stem cells in vivo by
inhibiting pro-apoptotic genes Bak1. This cluster was also up-
regulated expression in our rhesus monkey ESCs despite of origin
from parthenogenesis or IVF, suggesting the potential roles of this
cluster in ESCs and IPS. Consisting with Laurent and colleagues’
reports [14], miR-183–182 cluster, miR-103, miR-21 and miR-
378, which were reported to be related to many type carcinomas
[33–36], were also enriched in both types of rhesus monkey ESCs.
Our results revealed that rpESCs and IVF-origin rhesus monkey
ESCs represented high similarity with respect to comprehensive
miRNA expression pattern, especially for miRNAs which involved
in properties of stem cells. Since parthenogenetic ESCs were
considered as potential source for regeneration medicine, their
tumorigenesis risk should be comprehensively and carefully
evaluated. By comparing with IVF-origin rhesus monkey ESCs,
our results indicated that rpESCs would up- or down-regulated
some specific tumor-related miRNAs, in addition to up-regulating
of some oncogenic miRNAs in both type of rhesus monkey ESCs
mentioned above. Oncogenic miRNAs [37,38], including let-7
family, miR-374 family, miR-138, miR-195, miR-19a and miR-
200a, had more than twice expression level in rpESCs comparing
with their IVF counterparts. Reversely, tumor suppressor,
including miR-222, miR-342-3p, were remarkably down-regulat-
ed in rpESCs. These results, along with recent report that cell lines
from human parthenogenetic embryos had aberrant centriole
distribution [39], highlighted the tumorigenesis risk of partheno-
genetic ESCs.
X-chromosome inactivation, by which dosage compensation of
the sex chromosome is achieved, is widely presented in mammals
[40]. In mouse embryonic stem cells (mESCs) and mouse-induced
pluripotent stem cells (miPSCs) both X chromosomes are active,
and inactivation occurs during differentiation [41–43]. The
presence of two active X chromosomes have been considered as
one of epigenetic markers for murine ESCs. However, in human
ESCs or iPS, X chromosomes status represented complex
variations [44–46]. Especially, by changing culture and growth
factor condition, pre-X inactivation human ESCs or iPS could be
derived [47,48]. By collecting and analysing the expression of the
entire set of genes on the X chromosome, Bruck and colleagues
divided human pluripotent cell lines into three categories: no XCI,
full XCI, and partial XCI [49]. In current study, we collected and
analyzed the expression of the entire set of known miRNAs on the
X chromosome in our rhesus monkey ESCs. The X-linked
miRNAs in Pa3 rpESCs had about twice level of expression than
that of Pa2.2 rpESCs and their IVF counterparts, implying the
activation of both two of X chromosome in Pa3. In order to
validate this prediction, we checked XIST, a non-code RNA
which was specifically expressed in female cells and took part in
XCI. Expectably, XIST could not be detected in Pa3 rpESCs and
male rhesus monkey ESCs IVF3.3. Whereas, Pa2.2 expressed high
level of XIST, equal to female rhesus monkey ESCs IVF3.2. These
results suggested that the variations of X chromosome status were
also presented in parthenogenetic ESCs, regardless of the identical
origin of both X chromosome. Notably, in Rhesus monkey, both
X chromosomes are active in blastocyst stage from which ESCs
were isolated [50]. Therefore, XCI would occur during derivation
of ESCs.
Materials and Methods
Ethics Statement
Mature rhesus monkey were supplied by Kunming Primate
Research Center, and housed in individual cages when used for
the present study. This study was carried out in strict accordance
with the recommendations of the Weatherall report, ‘‘The use of
non-human primates in research’’. The protocols involving rhesus
monkey and mouse were approved by the Institutional Animal
Care and Use Committee(s)(IACUC) of the Kunming Primate
Research Center, the Chinese Academy of Sciences(approval ID:
20091007). All surgery was performed under sodium pentobarbital
anesthesia, and all efforts were made to minimize suffering.
Collection of Rhesus Monkey Oocytes,Parthenogenetic
Activation and Embryo Culture
Cycling females were subjected to follicular stimulation using
twice-daily intramuscular injections of 18 IU of recombinant
human FSH (rhFSH) (Gonal FTM Laboratories) for 8 d; then
1,000 IU of human chorionic gonadotropin (hCG) (Lizhu Groups)
were injected on day 9 as described by Yang et al [51]. Cumulus–
oocyte complexes were collected from animals by laparoscopic
follicular aspiration 30–34 h following hCG administration.
Follicular contents were placed in Hepesbuffered Tyrode’s
albumin lactate pyruvate (TALP) medium [52] containing 0.3%
BSA at 37uC. Oocytes were stripped of cumulus cells by pipetting
after brief exposure (,1 min) to hyaluronidase (0.5 mg/mL) in
TALP-Hepes to allow visual classification of nuclear maturity as
prophase I (PI; intact germinal vesicle), metaphase I (MI; no
germinal vesicle, no polar body), metaphase II (MII; first polar
body present), and atretic (presence of fragmentation or vacuoles
in ooplasm). Immature oocytes in either MI or PI stages were
cultured in a 50-mL drop of CMRL-1066 medium (Invitrogen)
containing 10% FBS, 10 IU/mL porcine FSH, and 10 IU/mL
ovine luteinizing hormone at 37uC in humidified air (5% CO2) for
up to 24 h. Oocytes that were mature (MII) at collection were
placed in chemically defined, protein-free hamster embryo culture
medium-10 (HECM-10) [53] at 37uCi n5 %C O 2 until
Figure 4. Comparison of miRNA expression between parthenogenetic and IVF rhesus monkey ESCs. A, heat-map of hierarchical
clustering of miRNAs expression in parthenogenetic and IVF rhesus monkey ESCs. Right shows miRNAs whose expression more than 10000 counts
TPM. B, miRNAs remarkable up- or down-regulated(fold-change.2,p,0.05) in rpESCs comparing with IVF rhesus monkey ESCs.
doi:10.1371/journal.pone.0025052.g004
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genetic activated by electroporation with two 40-msec direct
current pulses of 200 V/mm (BTX ECM-2000; BTX, Inc.,San
Diego, CA) in 0.25 M D-Mannitol buffer containing 0.05 mM
calcium chloride, 0.1 mM magnesium chloride, 0.5 mM Hepes,
and 0.02% fatty acid-free BSA. Electroporated oocytes were
exposure to 5 mM ionomycin (Calbiochem, La Jolla, CA) for
4 min in TALP/Hepes medium supplemented with 1 mg/ml BSA
and then washed for 5 min in TALP/Hepes supplemented with
30 mg/ml BSA; ionomycin-treated oocytes were then transferred
into CMRL-1066 medium containing 2 mM 6-dimethylaminop
urine (6-DMAP) and cultured at 37uCi n5 %C O 2 balance air for
5 h. After activation, oocytes were cultured in HECM-9
containing 10% FBS (HyClone Laboratories Inc.) to allow embryo
development. Culture medium was replaced every other day.
Embryonic Stem Cells Derivation and Culture
Full expanded blastocysts with distinct ICM were selected to
derivation of embryonic stem cells. Zonae pellucidae were
removed by brief exposure to 0.5% pronase, and ICM were
isolated using immunosurgery. Isolated ICM were plated on Nunc
four-well dishes containing mitotically inactivated mouse embry-
onic fibroblasts (mEFs) and cultured in Dulbecco’s Modified Eagle
Medium: Nutrient Mixture F-12 (DMEM/F12,Invitrogen)me-
dium containing 20% KO-SR (Invitrogen) supplemented with
10 ng/ml bFGF(Chemicon), 1% nonessential amino acids (Invi-
trogen), 0.1 mM b-mercaptoethanol(Invitrogen), 1% penicillin-
streptomycin-l-glutamate(PSG)(Invitrogen). ICM that attached to
the mEFs and initiated outgrowth were manually dissociated into
small cell clumps with a microscalpel and replated onto new mEFs.
After the first passage, colonies with ESC-like morphology were
selected for further propagation, characterization and freezing.
When all colonies were uniform ESC-like morphology, culture
medium were replaced by DMEM/F12 medium containing 20%
KO-SR supplemented with 5 ng/ml bFGF (Chemicon), 1%
nonessential amino acids, 0.1 mM b-mercaptoethanol, 1% PSG.
The medium was changed daily, and ESC colonies were split
every 4–6 days manually or by disaggregation in collagenase IV
(1 mg/ml, at 37uC for 15 minutes; Invitrogen) and replating onto
dishes with fresh feeder layers. Cultures were maintained at 37uC,
in 5% CO2.
In vitro Differentiation of ESCs
For embryoid body (EB) formation, entire ESCs colonies were
detached from feeder cells by exposure to collagenase IV (1 mg/
ml, at 37uC for 15 minutes) and transferred into agar-coated
dishes and cultured in suspension in Dulbecco.s modified Eagle.s
medium (DMEM, high glucose, without sodium pyruvate;
Gibco)containing 20% FBS, 1% nonessential amino acids,
0.1 mM b-mercaptoethanol, 1% PSG. After 5–7days, EBs were
transferred into gelatin-coated dishes allowing attachment for
further differentiation. Medium was changed every other day.
Teratoma Formation
Entire ESCs colonies were detached from feeder cells by
exposure to collagenase IV (1 mg/ml, at 37uC for 15 minutes) and
about 2 million undifferentiated ESCs from each cell line were
harvested and injected into the hind leg muscle into 4-week-old
SCID, male mice using an 18-gauge needle. 6–7 weeks after
injection, mice were sacrificed, and teratomas were dissected,
sectioned, and histologically characterized for the presence of
representative tissues of all three germ layers.
Immunohistochemical Staining
Cells were fixed with 4% paraformaldehyde in PBS for
20 minutes at room temperature, and permeabilized in 0.1%Tri-
tonX-100 in PBS for 10 minutes at room temperature. After
blocked with 3% BSA, cells were stained with primary antibodies.
Cells were then rinsed three times with PBS and incubated for
60 minutes with fluorescein isothiocyanate (FITC)-conjugated
secondary antibody (Santa Cruz Biotechnology). Negative controls
for each fluorophore- conjugated secondary antibody were carried
out without the addition of the primary antibody, and nonspecific
binding of secondary antibodies was detected.
Reverse Transcription-Polymerase Chain Reaction
Total RNA was extracted using a TRIZOL RNA isolation kit
(Invitrogen Corporation) according to the manufacturer’s instruc-
tions. Potential contamination from genomic DNA was eliminated
by DNase digestion. Cytoplasmic RNA was reverse-transcribed to
single-stranded cDNA. Aliquots of cDNA were used as a template
for polymerase chain reaction (PCR) amplification with individual
primer pairs for specific genes. The sense and antisense primer
sequences, corresponding PCR condition, and product sizes were
shown in Table S1. 5 ml of PCR products were separated on a
1.5% agarose gel and visualized by ethidium bromide staining.
Cytogenetic Analysis
Mitotically active ESCs in log phase were incubated with
120 ng/ml colcemid for 90 minutes at 37uC in 5% CO2. Entire
ESCs colonies were detached from feeder cells by exposure to
collagenase IV (1 mg/ml, at 37uC for 15 minutes), treated with
0.05% trypsin at 37uC for 2 minutes and centrifuged at 200 g for
5 minutes. The cell pellet was gently resuspended in 0.075 M KCl
and incubated for 20 minutes at 37uC followed by fixation with
methanol/glacial acetic acid (3:1). Fixed cells were dropped on wet
slides, air dried, and baked at 90uC for 1 hour. G-banding was
performed as described previously [54].
Alkaline Phosphatase Staining
Alkaline Phosphatase staining was performed using Alkaline
Phosphatase Detection Kit(Catalog number SCR004, Millipore).
Single-nucleotide Polymorphism (SNP) Analysis
Total genomic DNA was extracted using the DNeasy Tissue Kit
(Qiagen) and SNP analysis was performed using polymerase chain
reaction-sequence specific primer(PCR-SSP).
RNA Extraction and Small RNA Sequencing
Total RNA was extracted using the mirVana miRNA isolation
kit (Ambion). According to the manufacturer’s instructions
(Illumina), small RNA fraction between 18–30 nt was isolated
Figure 5. Analysis of X-chromosome status in rpESCs based on miRNAs expression. A, box plot of the entire set of kwon miRNAs on X or 1
chromosome. Left, X-chromosome, right, 1-chromosome. (*, p,0.05). B, moving average plot of the X or 1 chromosome. Shown are relative gene
expression levels along the X or 1 chromosome. Left, X-chromosome, right, 1-chromosome. IVF3.2 rhesus monkey ESCs(female,green), IVF3.3 rhesus
monkey ESCs (male, blue), Pa2.2 rpESCs (mauve) and Pa3 rpESCs(red). C, analysis of XIST expression by semi- quantitive PCR. Histogram showed
relative XIST expression in IVF3.2 rhesus monkey ESCs (female, green), IVF3.3 rhesus monkey ESCs (male, blue), Pa2.2 rpESCs(mauve) and Pa3 rpESCs
(red).The relative XIST expression was XIST:GAPDH ratio.
doi:10.1371/journal.pone.0025052.g005
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adaptors to their 59 and 39 ends. Then the small RNA were
converted to cDNA by RT-PCR and amplified using the adaptor
primers. The purified DNA was used directly for cluster
generation and sequencing analysis by the Illumina Genome
Analyzer. These data have been deposited in the GEO database
(GSE30510).
Small RNA Annotation and Novel miRNAs Prediction
To obtain clean reads, the original 35 nt reads from sequencing
were filtered by trimming the 39 adaptors, getting rid of
contaminant, too-small (,18 nt) and low-quality reads. The
resulting unique sequences with associated read counts were taken
as sequence tags. The clean reads were aligned with Genbank and
Rfam 9.1database using BLASTn, for removing non-miR-
NAs(rRNA, tRNA, etc). For detecting the known miRNAs, the
clean reads were matched to the reference miRNA precursor
sequences of rhesus macaque (miRBase version16.0) using
BLASTn software, with the parameter Expect value at 0.01. For
identifying repeat associated RNA and degradation tags of
mRNA, the clean reads were overlapped to repeat sequences,
exons and introns of mRNAs. In the initial alignment and
annotation, some small RNA tags were mapped to more than one
category. To obtain uniquely mapped reads, we applied the
following priority rules: rRNAetc (in which Genbank . Rfam) .
known miRNA . repeat . exon . intron. The unannotated
small RNA tags are named as ‘unann’. We used Mireap (http://
sourceforge.net/projects/mireap/) to predict novel miRNAs.
Differential Expression of Known miRNA
Normalization of the expression of miRNA was conducted in
order to get the expression of transcript per million (TPM).
Normalization formula: Normalized expression=Actual miRNA
count/Total count of clean reads61000000. Based on the
randomly selected 210,000 bins (10,000 bins multiply 21
chromosomes) with each bin spanning 50 bp window, we filtered
out miRNAs with sporadic reads which may be generated from
potential noise, and miRNAs with normalized reads no less than 3
TPM (p-value ,0.0001 based on Poisson distribution simulation)
were treated as true reads for further analyses. MiRNAs were
considered to belong to the same genomic cluster if the genomic
locations of the first nucleotides of the predicted pre-miRNA
hairpins were within 10 kilobases (kb).The fold-change of the
expression of miRNA between two samples were showed as Log2-
ratio.
X-linked miRNAs Analysis
We collected X-linked miRNAs in rhesus monkey ESCs
expression data from this study and our prevenient report [19]
In order to making a reference baseline, the median of normalized
counts of each X-linked miRNAs in male rESCs was used. Then
each sample were divided by this median to obtain relative gene
expression levels, and were represented as log2 ratio. For
visualization of these fold-change values on X chromosome, a
freely available comparative genomic hybridization (CGH)
analysis software program, CGH-Explorer [55] was used. Moving
average plot of X chromosomes was drawn using the moving
average fit tool. On the other hand, we simultaneously used 1-
chromosome as control.
Supporting Information
Figure S1 The PCR result for ESCs-crucial transcrip-
tional factors.
(TIF)
Table S1 PCR primers and condition for gene analysis.
(DOC)
Table S2 Absolute counts of known miRNAs in Pa2.2
and Pa3.
(XLS)
Table S3 The expression of members of miR-371–373
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Table S4 Novel miRNAs in Pa2.2 and Pa3.
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